Kriya Therapeutics
Erik Hughes is the Senior Vice President, Technical Development at Kriya Therapeutics. Dr. Hughes joins Kriya from Biogen where he held various roles included Director of Global Process Sciences and Director of North American Manufacturing Sciences. Within these roles, he was responsible for partner relationships, development of second-generation processes, technology transfer, process scale-up, GMP cell banking. process compliance, and lifecycle management across a portfolio of commercial and clinical products. Prior to Biogen, Dr. Hughes started his career at Wyeth Research where he worked in upstream process development on Prevnar13® and a meningococcal group B vaccine.
Dr. Hughes received his Ph.D. in chemical engineering and his undergraduate de in economics and chemical engineering from Rice University.
This person is not in any offices
Kriya Therapeutics
2 followers
Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs.